DALLAS, TX October 2, 2015 North American Cannabis Holdings, Inc. (USMJ) Today Announced that NaturesComfortMeds has been awarded two patents by The United States Patent and Trademark Office (USPTO). The USPTO is an agency in the U.S. Department of Commerce that issues patents to inventors and businesses for their inventions, and trademark registration for product and intellectual property identification.
“NaturesComfortMeds has achieved a monumental milestone. On behalf of North American Cannabis Holdings, we all applaud the hard work and extend a hearty congratulation,” said Steven Rash, CEO of North American Cannabis Holdings.
North American Cannabis Holdings featured its JV agreement with NaturesComfortMeds recently in conjunction with the Company’s agreement to move its cannabis consumer health product operations under Puration, Inc. (PURA). North American Cannabis Holdings exchanged its cannabis consumer health product operations for preferred stock of Puration. A portion of the Puration preferred stock is slated for conversion into Puration common stock to be distributed to North American Cannabis Holdings shareholders through a dividend distribution.
NaturesComforMeds has been awarded two patents in conjunction with a proprietary Cannabidiol, or CBD, extraction process. This proprietary extraction process is instrumental to the joint venture agreement with North American Cannabis Holdings, Inc. to develop health and wellness cannabis consumer products. Products under development include treatments for cancer and post traumatic stress disorder (PTSD).
Learn more about NaturesComfortMeds at http://www.naturescomfortmeds.org/
About North American Cannabis Holdings, Inc.
North American Cannabis Holdings, Inc. (USMJ) is founded on the core belief that cannabis makes people's lives better. Cannabis can fight disease, improve wellness and do so in an environmentally sustainable manner. North American Cannabis Holdings is dedicated to finding the best possible applications for cannabis to serve consumers. For more information please visit www.growusmj.com.
Follow the company on Twitter: http://twitter.com/US_HEMP.
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and as such, may involve risks and uncertainties. These forward looking statements relate to, amongst other things, current expectation of the business environment in which the company operates, potential future performance, projections of future performance and the perceived opportunities in the market. The company's actual performance, results and achievements may differ materially from the expressed or implied in such forward-looking statements as a result of a wide range of factors.